These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8370383)

  • 1. Radiochemical purity of iodine-131 labelled metaiodobenzylguanidine infusion fluids: a report from clinical practice.
    Wafelman AR; Suchi R; Hoefnagel CA; Beijnen JH
    Eur J Nucl Med; 1993 Jul; 20(7):614-6. PubMed ID: 8370383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiochemical stability during infusion of 131I-labelled metaiodobenzylguanidine for therapeutic use.
    Wafelman AR; Hoefnagel CA; Beijnen JH
    Nucl Med Commun; 1993 Sep; 14(9):819-22. PubMed ID: 8233249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion.
    Wafelman AR; Hoefnagel CA; Maes RA; Beijnen JH
    Nuklearmedizin; 1996 Aug; 35(4):122-5. PubMed ID: 8784866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours.
    Wafelman AR; Hoefnagel CA; Maessen HJ; Maes RA; Beijnen JH
    Eur J Nucl Med; 1997 May; 24(5):544-52. PubMed ID: 9142736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [131I]metaiodobenzylguanidine treatment of a malignant paraganglioma.
    Baulieu JL; Guilloteau D; Calais G; Lefloch O; Besnard JC
    J Nucl Biol Med (1991); 1991; 35(4):313-4. PubMed ID: 1823844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
    Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
    Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of [131I]metaiodobenzylguanidine therapy in medullary thyroid carcinoma.
    Hoefnagel CA; Delprat CC; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):334-6. PubMed ID: 1823851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
    Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [131I]metaiodobenzylguanidine therapy in paraganglioma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Crippa F; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):315-7. PubMed ID: 1823845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effectiveness of iodine-131 MIBG metastases of a nonsecreting paraganglioma.
    Baulieu JL; Guilloteau D; Baulieu F; Le Floch O; Chambon C; Pourcelot L; Besnard JC
    J Nucl Med; 1988 Dec; 29(12):2008-13. PubMed ID: 3193214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefit.
    Tristam M; Alaamer AS; Fleming JS; Lewington VJ; Zivanovic MA
    J Nucl Med; 1996 Jun; 37(6):1058-63. PubMed ID: 8683301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
    Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
    J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
    Gaze MN; Mairs RJ; Boyack SM; Wheldon TE; Barrett A
    Br J Cancer; 1992 Dec; 66(6):1048-52. PubMed ID: 1457344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine.
    Khafagi FA; Shapiro B; Fischer M; Sisson JC; Hutchinson R; Beierwaltes WH
    Eur J Nucl Med; 1991; 18(3):191-8. PubMed ID: 1645665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    J Nucl Med; 1987 Mar; 28(3):308-14. PubMed ID: 3102701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations on 131I-metaiodobenzylguanidine therapy of six children with neuroblastoma.
    Sanguineti M
    Med Pediatr Oncol; 1987; 15(4):212-5. PubMed ID: 3657710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.
    Mangner TJ; Tobes MC; Wieland DW; Sisson JC; Shapiro B
    J Nucl Med; 1986 Jan; 27(1):37-44. PubMed ID: 3941363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W; Weber J; Senekowitsch-Schmidtke R
    Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
    Mastrangelo R; Lasorella A; Troncone L; Rufini V; Iavarone A; Riccardi R
    J Nucl Biol Med (1991); 1991; 35(4):252-4. PubMed ID: 1823829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.